Hanwen Lu
Xiamen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
LPIN3 emerges as a diagnostic biomarker in Moyamoya disease revealing immune-lipid metabolic crosstalk.
Journal: Frontiers in genetics
Published: April 12, 2026
CSRP2 promotes the glioblastoma mesenchymal phenotype via p130Cas-mediated NF-κB and MAPK pathways.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 13, 2025
The combination of temozolomide and perifosine synergistically inhibit glioblastoma by impeding DNA repair and inducing apoptosis.
Journal: Cell death discovery
Published: February 07, 2024
Ketogenic β-hydroxybutyrate regulates β-hydroxybutyrylation of TCA cycle-associated enzymes and attenuates disease-associated pathologies in Alzheimer's mice.
Journal: Aging cell
Published: January 09, 2024
Deciphering the prognostic significance of WDR77 in gliomas: a comprehensive analysis.
Journal: Scientific reports
Published: September 26, 2023
Sitravatinib is a potential EGFR inhibitor and induce a new death phenotype in Glioblastoma.
Journal: Investigational new drugs
Published: February 22, 2023
Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma.
Journal: Frontiers in medicine
Published: May 09, 2022
New Autophagy-Ferroptosis Gene Signature Predicts Survival in Glioma.
Journal: Frontiers in cell and developmental biology
Published: July 10, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026